entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100506637,PRKAR2A-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,15.9167335512976,0.275768841966869,0.527288111363946,0.522994613425918,0.600978001744987,0.961473650102656,NA
100506637,PRKAR2A-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,14.1406900487484,-1.08067504886054,0.51370244302082,-2.10369848059442,0.0354047570920836,0.205823313968397,patient-derived GBM cell lines (PDGCLs)
100506637,PRKAR2A-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,23.4849665043553,-0.321859779422028,0.428994985713713,-0.750264665416903,0.453095319247005,0.858626645745507,A549
100506637,PRKAR2A-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,19.8003185127172,-0.463098677967614,0.444734296156606,-1.04129292921574,0.297739617335789,0.986418245486816,A549
100506637,PRKAR2A-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,29.2492682980429,-0.556456377792387,0.558352115555111,-0.996604762998276,0.318956393122017,0.621598119172467,A549
100506637,PRKAR2A-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,15.9060256006913,0.198052485051879,0.502823268929707,0.393880906652246,0.693668967536475,1,sigmoid colon organoid
100506637,PRKAR2A-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,15.9060256006913,-0.61978290000361,0.527707604570537,-1.17448165354374,0.240202156287274,0.978600907828468,sigmoid colon organoid
